FDA Approves First-Ever 'Pill' With Digital Tracking System

FDA Approves First-Ever 'Pill' With Digital Tracking System Photo: Photo:

November 14, 2017 12:05 PM

WASHINGTON (AP) - The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.
The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."
Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."



(Copyright 2017 by The Associated Press. All Rights Reserved.)

Relay Media Amp

Most Read Stories

Burton Iverson of Pittsville, Adell (Fenne) Jenness and Lou Ann (Rossi) Maxson.

West Concord Class of 1943 Holds 75th Consecutive Renuion

Woman Accused of Threatening Man with Machete and Hatchet

Gas Line Cut by Burglar in SW Rochester Home

911 Service Out In Part of Freeborn County

Passport, Drivers License, and Blank Checks Stolen from Oronoco Home

Man Saved; Two Dogs Dead after House Fire in Byron